BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Waldenstrom Macroglobulinemia

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Waldenstrom Macroglobulinemia:

Pubmed Logo
Development of EBV-associated diffuse large B-cell lymphoma in Waldenstrom macroglobulinemia and mantle cell lymphoma.
This review focuses on the contributions of the central thalamus to normal...
9th July, 2008
Department of Haematology, Hull Royal Infirmary, Hull, UK. Leuk Lymphoma. 2008 May 2;:1-2.
DOI Direct Link
Multiple myeloma and immunosecretory disorders: an update.
The immunosecretory disorders are a diverse group of diseases associated...
27th June, 2008
Department of Pathology, Veterans Affair Medical Center, Louisville, KY, Adv Anat Pathol. 2008 Jul;15(4):196-210.
DOI Direct Link
Waldenstrom Macroglobulinemia.
In the past years, new developments have occurred both in the...
17th June, 2008
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Cancer Lett. 2008 Jun 12;.
DOI Direct Link
Irreversible visual loss and optic nerve dysfunction associated with central retinal vein occlusion in Waldenstrom Macroglobulinemia.
Irreversible optic nerve dysfunction associated with central retinal vein...
17th June, 2008
Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Med J Malaysia. 2007 Oct;62(4):349-51.
Lymphomatous neuropathy in cold agglutinin disease.
Waldenstrom macroglobulinemia (WM) is a B-cell malignancy that remains...
7th June, 2008
Department of Neurology, San Raffaele Scientific Institute, Via Olgettina Neurology. 2008 May 6;70(19):1715-6.
DOI Direct Link

View more research publications.

BioNews Results for Waldenstrom Macroglobulinemia:

RSS Logo
BioPortfolio Logo
Combo Therapy Improves Response Rates in Waldenstrom's Macroglobulinemia
Medscape:  Jun 13 2008 3:49PM Matching: waldenstrom macroglobulinemia
Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Re
KOTA Territory News:  Jun 3 2008 3:14PM Matching: waldenstrom macroglobulinemia
Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Re
Yahoo! Canada:  Jun 3 2008 2:11PM Matching: waldenstrom macroglobulinemia
Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Re
KLFY:  Jun 3 2008 1:57PM Matching: waldenstrom macroglobulinemia
Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Re
Houston Chronicle:  Jun 3 2008 1:48PM Matching: waldenstrom macroglobulinemia
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Waldenstrom Macroglobulinemia Clinical Trials:

Clinical Trials Logo
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Leukemia;   Lymphoma
Monoclonal Antibody Therapy in Treating Patients With Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
Leukemia;   Lymphoma
Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
Leukemia;   Lymphoma
Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia
Leukemia;   Lymphoma
Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia
Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm

View more trials.

Waldenstrom Macroglobulinemia Patents:

USPTO Logo
US Patent No.Title
7329529 Ubiqutin proteases
7351545 IGF binding proteins
7351566 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552, and 65577 molecules and uses therefor
7351729 JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
7351739 Bioactive compounds and methods of uses thereof

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Waldenstrom Macroglobulinemia scientists - we have details of around 396 individuals working on Waldenstrom Macroglobulinemia .


This page has been viewed 156 times
Recent Search Terms used to find this page: waldenstrom s 2008 | waldenstrom s 2008 | waldenstrom s 2008 | 2008 waldenstroms | waldenstrom s macroglobinemia | waldenstrom s clincal trials | waldenstrom s clincal trials | waldenstrom macroglobulinemia | waldenstrom macroglobulinemia | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Waldenstrom Macroglobulinemia across BioPortfolio, or bestselling Waldenstrom Macroglobulinemia books or recently published Waldenstrom Macroglobulinemia books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional